Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Pharmaceuticals					276.91M	136.26M
Pharmaceuticals Growth					103.21%	-
Total					276.91M	136.26M
Total Growth					103.21%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
China					276.91M	136.26M
China Growth					103.21%	-
Total					276.91M	136.26M
Total Growth					103.21%	-

Source: S&P Global Market Intelligence.